Case Studies
Acutus Medical (NASDAQ: AFIB)
Interview with David Roman, CEO […]
Spotlight
Featured Interviews
Zerify (OTCQB: ZRFY)
Interview with Mark Kay, CEO and Chairman […]
Featured Interviews
Zomedica Corp. (NYSE American: ZOM)
ABOUT: Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include […]
CEO Interviews
WISekey International Holding Ltd (NASDAQ: WKEY) and Casper Networks
INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today are Carlos Moreira the CEO for WISekey International Holding Limited the company trades […]
Spotlight
Citius Pharmaceuticals (NASDAQ: CTXR)
Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]
Spotlight
Citius Pharmaceuticals (NASDAQ: CTXR) CEO Interview Update
Mino-Lok product has advanced to Phase 3 clinical studies. CITI-101 (Mino-Wrap) is a bio-absorbable film impregnated with minocycline and rifampin for reducing acute inflammation and microbial colonization of breast tissue expanders used in breast reconstruction surgeries following mastectomies. CITI-002 is being developed for symptomatic relief of hemorrhoids. CITI-002 combines the high-potency steroid, halobetasol, with lidocaine. […]
Biotech
Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals
About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]
Healthcare
Generex Biotechnology (OTCQB: GNBT) Completes Key Acquisitions and Announces Plans to List on NASDAQ
Generex Biotechnology Corp. (OTCQB:GNBT) is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that […]
CEO Interviews
Natural Shrimp, Inc’s (OTC: SHMP) Patented Technology is in Place and the Company is Ready for Growth
About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]
Biotech
Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]